Friday, June 12, 2026

Patent directory Β· USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code β€” or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 136 of 1,261
  1. US 11904025

    Cyclophanes for live-cell imaging

    Northwestern University Β· Granted Feb 20, 2024 Β· Expires Feb 15, 2044

    granted
  2. US 11904017

    Methods for reducing or eliminating the need for lipoprotein apheresis in patients with hyperlipidemia by administering alirocumab

    REGENERON PHARMACEUTICALS, INC. Β· Granted Feb 20, 2024 Β· Expires Feb 15, 2044

    granted
  3. US 11905268

    Anthranilic acid derivatives and their use in the treatment of human cancers

    SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE Β· Granted Feb 20, 2024 Β· Expires Feb 15, 2044

    granted
  4. US 11906519

    Methods for identifying LILRB-blocking antibodies

    The Board of Regents of the University of Texas System Β· Granted Feb 20, 2024 Β· Expires Feb 15, 2044

    granted
  5. US 11903966

    Intracellular genomic transplant and methods of therapy

    Regents of the University of Minnesota Β· Granted Feb 20, 2024 Β· Expires Feb 15, 2044

    granted
  6. US 11904057

    Nanoparticle-hydrogel composite for nucleic acid molecule delivery

    The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Feb 20, 2024 Β· Expires Feb 15, 2044

    granted
  7. US 11905276

    Bicyclic compound that acts as CRBN protein regulator

    Medshine Discovery Inc. Β· Granted Feb 20, 2024 Β· Expires Feb 15, 2044

    granted
  8. US 11903967

    Method of preparing T cells with increased activity

    AUTOLUS LIMITED Β· Granted Feb 20, 2024 Β· Expires Feb 15, 2044

    granted
  9. US 11903945

    Methods of treating antipsychotic-induced weight gain with miricorilant

    Corcept Therapeutics Incorporated Β· Granted Feb 20, 2024 Β· Expires Feb 15, 2044

    granted
  10. US 11904015

    Vaccine compositions and methods of use

    PDS Biotechnology Corporation Β· Granted Feb 20, 2024 Β· Expires Feb 15, 2044

    granted
  11. US 11903936

    Anti-malarial agents

    The Board of Regents of the University of Texas System Β· Granted Feb 20, 2024 Β· Expires Feb 15, 2044

    granted
  12. US 11903920

    Cannabinoid formulation: production method and use

    CHIROSYN DISCOVERY TECHNOLOGIES INC. Β· Granted Feb 20, 2024 Β· Expires Feb 15, 2044

    granted
  13. US 11903930

    Methods and compositions for treatment of epileptic disorders

    OVID THERAPEUTICS INC. Β· Granted Feb 20, 2024 Β· Expires Feb 15, 2044

    granted
  14. US 11903973

    Genetically engineered hematopoietic stem cells and uses thereof

    Vor Biopharma Inc. Β· Granted Feb 20, 2024 Β· Expires Feb 15, 2044

    granted
  15. US 11903952

    Vitamin D as an immune modulator to prevent immune-related complication from COVID-19 infection

    The Regents of the University of Colorado Β· Granted Feb 20, 2024 Β· Expires Feb 15, 2044

    granted
  16. US 11903994

    Dosing regimens

    Apellis Pharmaceuticals, Inc. Β· Granted Feb 20, 2024 Β· Expires Feb 15, 2044

    granted
  17. US 11904052

    Methods for ameliorating infusion reactions

    ARBUTUS BIOPHARMA CORPORATION Β· Granted Feb 20, 2024 Β· Expires Feb 15, 2044

    granted
  18. US 11905327

    Single-domain antibodies and variants thereof against TIGIT

    Nanjing Legend Biotech Co., Ltd Β· Granted Feb 20, 2024 Β· Expires Feb 15, 2044

    granted
  19. US 11904007

    Protection from stress, anxiety, neuroinflammation, and cognitive dysfunction

    The Regents of the University of Colorado, a Body Corporate Β· Granted Feb 20, 2024 Β· Expires Feb 15, 2044

    granted
  20. US 11905320

    T-cell modulatory multimeric polypeptides and methods of use thereof

    Cue Biopharma, Inc. Β· Granted Feb 20, 2024 Β· Expires Feb 15, 2044

    granted
  21. US 11905332

    Antigen-binding molecules that bind CD38 and/or CD28, and uses thereof

    REGENERON PHARMACEUTICALS, INC. Β· Granted Feb 20, 2024 Β· Expires Feb 15, 2044

    granted
  22. US 11904006

    Poly(diaminosulfide) particle-based vaccine

    The United States of America, as represented by the Secretary of Agriculture Β· Granted Feb 20, 2024 Β· Expires Feb 15, 2044

    granted
  23. US 11904046

    Hydrocortisone oral liquid formulations

    Eton Pharmaceuticals, Inc. Β· Granted Feb 20, 2024 Β· Expires Feb 15, 2044

    granted
  24. US 11905285

    Inhibitors of plasma kallikrein and uses thereof

    Takeda Pharmaceutical Company Limited Β· Granted Feb 20, 2024 Β· Expires Feb 15, 2044

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search β€” best for looking up a specific filing or applicant portfolio slice.